Research Articles
Nature's Hidden Key: How a Plant Compound Could Revolutionize Breast Cancer Treatment
Discover how α-Cyperone, a compound from Cyperus rotundus, targets TRIM24 protein to combat breast cancer development and chemotherapy resistance.
How a Tiny Protein Could Revolutionize Treatment for Severe Pancreatitis
Discover how Pellino1 protein protects against severe acute pancreatitis by suppressing necroptosis and promoting RIP3 degradation.
Disarming Cancer: How a Tiny Engineered Peptide Helps Thwart a Key Cancer Pathway
Discover how selective peptide binders of RNF43 offer new hope for Wnt signaling inhibition in cancer treatment.
Cracking the PROTAC Code: How AI is Revolutionizing the Fight Against 'Undruggable' Diseases
Discover how PROTAC-STAN, an AI-powered framework, is transforming targeted protein degradation to combat previously undruggable diseases through interpretable predictions.
PROTAC-Based HDAC Degradation: A Paradigm Shift in Targeted Epigenetic Therapies
Explore the revolutionary approach of PROTAC-based HDAC degradation in epigenetic cancer therapy, moving beyond inhibition to complete protein elimination.
Disarming a Superbug: How Digital DNA Could End Cholera's Stubborn Streak
Discover how scientists are using computer-designed DNA aptamers to disrupt cholera biofilms and combat antibiotic resistance through molecular dynamics simulations.
F-Box Proteins: The Cellular Guardians Navigating Cancer Immunity
Explore how F-box proteins regulate ubiquitination and influence tumor immunity, with insights into research methods and therapeutic potential.
The New Frontier in Concussion Care: How Biomarker Technology is Revolutionizing Diagnosis
Explore how neurologic concussion biomarkers are transforming diagnosis through point-of-care testing, enabling faster and more accurate detection of traumatic brain injuries.
Unlocking Alzheimer's: How Brain Inflammation Reveals New Therapeutic Targets
Explore how brain inflammation research is revealing new therapeutic targets for Alzheimer's disease through laboratory models and cutting-edge experiments.
The Invisible Architect of Prostate Cancer: How UHRF1 Phase Separation Drives Disease
Groundbreaking discovery reveals how UHRF1 phase separation drives prostate cancer progression through epigenetic mechanisms.